OUABAIN IS NOT DETECTABLE IN HUMAN PLASMA

被引:78
作者
LEWIS, LK
YANDLE, TG
LEWIS, JG
RICHARDS, AM
PIDGEON, GB
KAAJA, RJ
NICHOLIS, MG
机构
[1] CHRISTCHURCH HOSP,DEPT MED,CHRISTCHURCH,NEW ZEALAND
[2] CHRISTCHURCH HOSP,DEPT ENDOCRINOL,CHRISTCHURCH,NEW ZEALAND
[3] CHRISTCHURCH HOSP,DEPT NEPHROL,CHRISTCHURCH,NEW ZEALAND
[4] CHRISTCHURCH HOSP,DEPT CARDIOL,CHRISTCHURCH,NEW ZEALAND
[5] UNIV HELSINKI,CENT HOSP,DEPT OBSTET & GYNECOL,SF-00290 HELSINKI,FINLAND
关键词
OUABAIN; HYPERTENSION; ESSENTIAL; SODIUM;
D O I
10.1161/01.HYP.24.5.549
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
An enzyme-linked immunosorbent assay is described for the measurement of ouabain in human plasma. This assay is specific for ouabain, strophanthidin, and ouabagenin, with other steroids, including digoxin and vasopressor hormones, exhibiting negligible cross-reactivity. Assay sensitivity was 0.06 nmol/L if 1 mL plasma was extracted and less than 0.005 nmol/L when 20 mL plasma was analyzed. Extracted plasma samples showed ouabainlike immunoreactivity that diluted in parallel with the ouabain standard curve. Repeated extraction and assay of single plasma samples, however, did not produce consistent results in the assay. Increased specificity was obtained by high-performance liquid chromatography of sample extracts before assay. When high-performance liquid chromatographic profiles of plasma spiked with ouabain standard or following bolus intravenous injections of ouabain into normal human Volunteers were compared with profiles of unspiked plasma, there was no support for the immunoreactive material in the latter samples being ouabain. We propose that if ouabain is present in the human circulation, its concentration is less than 0.005 nmol/L.
引用
收藏
页码:549 / 555
页数:7
相关论文
共 35 条
[1]   PHYSIOLOGICAL-EFFECTS OF ENDOGENOUS OUABAIN - CONTROL OF INTRACELLULAR CA-2+STORES AND CELL RESPONSIVENESS [J].
BLAUSTEIN, MP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (06) :C1367-C1387
[2]   OUABAIN IS SECRETED BY THE ADRENAL-GLAND IN AWAKE DOGS [J].
BOULANGER, BR ;
LILLY, MP ;
HAMLYN, JM ;
LAREDO, J ;
SHURTLEFF, D ;
GANN, DS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (03) :E413-E419
[3]  
BRICKER NS, 1970, ARCH INTERN MED, V126, P860
[4]   EVIDENCE OF AN ENDOGENOUS-DIGITALIS-LIKE-FACTOR IN THE PLASMA OF PATIENTS WITH ACROMEGALY [J].
DERAY, G ;
RIEU, M ;
DEVYNCK, MA ;
PERNOLLET, MG ;
CHANSON, P ;
LUTON, JP ;
MEYER, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (10) :575-580
[5]  
Editorial, 1991, LANCET, V338, P543
[6]   SOME EFFECTS OF DIGOXIN UPON THE HEART AND CIRCULATION IN MAN - DIGOXIN IN COMBINED (LEFT AND RIGHT) VENTRICULAR FAILURE [J].
FERRER, MI ;
CONROY, RJ ;
HARVEY, RM .
CIRCULATION, 1960, 21 (03) :372-385
[7]   OUABAIN ENHANCES THE MITOGENIC EFFECT OF SERUM IN VASCULAR SMOOTH-MUSCLE CELLS [J].
GOLOMB, E ;
HILL, MR ;
BROWN, RG ;
KEISER, HR .
AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (01) :69-74
[8]   ELEVATED CONCENTRATIONS OF ENDOGENOUS OUABAIN IN PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
GOTTLIEB, SS ;
ROGOWSKI, AC ;
WEINBERG, M ;
KRICHTEN, CM ;
HAMILTON, BP ;
HAMLYN, JM .
CIRCULATION, 1992, 86 (02) :420-425
[9]   VOLUME EXPANSION IN RENAL-FAILURE PATIENTS - A PARADIGM FOR A CLINICALLY RELEVANT [NA,K]ATPASE INHIBITOR [J].
GRAVES, SW ;
GLATTER, KA ;
LAZARUS, JM ;
WILLIAMS, GH ;
HOLLENBERG, NK .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 :S54-S57
[10]  
GUTHRIE GP, 1984, J CLIN ENDOCR METAB, V58, P76